Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1017/S1047951120004291 http://scihub22266oqcxt.onion/10.1017/S1047951120004291 33183365!7737124!33183365     free     free     free       Cardiol+Young 2021 ; 31 (3): 507-510 Nephropedia Template TP {{tp|p=33183365|t=2021. Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease |pdf=|usr=}}{{33183365}} gab.com Text Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease JO: Cardiol Young http://www.kidney.de/pget.php?&tw=1&pmid=33183365 #FOAvip The large outbreak of coronavirus disease 2019 (COVID-19) is spreading all over the world rapidly. There have recently been publications in the literature regarding the relationship between COVID-19 and Kawasaki disease, but there is no sufficient knowledge about the treatment and follow-up. Twit Text FOAVip Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease ????Cardiol Young http://www.kidney.de/pget.php?&tw=1&pmid=33183365 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33183365 #FOAvip English Wikipedia <ref>{{Cite pmid|33183365}}</ref> Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease #MMPMID33183365 Orbak Z; Laloglu F; Akat H Cardiol Young 2021[Mar]; 31 (3): 507-510 PMID33183365show ga The large outbreak of coronavirus disease 2019 (COVID-19) is spreading all over the world rapidly. There have recently been publications in the literature regarding the relationship between COVID-19 and Kawasaki disease, but there is no sufficient knowledge about the treatment and follow-up. |*COVID-19 Drug Treatment[MESH] |*Oxygen Inhalation Therapy[MESH] |Ampicillin/therapeutic use[MESH] |Anti-Bacterial Agents/therapeutic use[MESH] |Anticoagulants/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Azithromycin/therapeutic use[MESH] |COVID-19 Nucleic Acid Testing[MESH] |COVID-19 Serological Testing[MESH] |COVID-19/complications/diagnostic imaging/physiopathology[MESH] |Child[MESH] |Drug Combinations[MESH] |Enoxaparin/therapeutic use[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use[MESH] |Hypoxia/etiology/physiopathology/*therapy[MESH] |Immunoglobulins, Intravenous/therapeutic use[MESH] |Immunologic Factors/therapeutic use[MESH] |Lopinavir/*therapeutic use[MESH] |Lung/diagnostic imaging[MESH] |Male[MESH] |Mucocutaneous Lymph Node Syndrome/*drug therapy/etiology/physiopathology[MESH] |Oseltamivir/therapeutic use[MESH] |Ritonavir/*therapeutic use[MESH] |Sulbactam/therapeutic use[MESH]Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in (epmc).pdf DeepDyve Pubget Overpricing